JAK2 and breast carcinoma: This observation, coupled with the detection of elevated expression of CISH protein in primary human breast cancers, has led to the hypothesis that PRL-induced CISH expression may facilitate the pathogenesis of breast cancer by enhancing cell proliferation triggered by Jak2/MAPK activity at the expense of cell differentiation mediated by Stat5 [16].